The Department of Health Covid Vaccination Dashboard
The Green Book : Chapter 14a
- The coronavirus (COVID-19) vaccines
- The dosage and schedule for the UK & recommendations for use
HSCB Resources
HSS(MD)35/2021 – USE OF THE ASTRAZENECA VACCINE: ADVICE ON UPDATED JCVI STATEMENT 11/05/21
PHA – COVID-19 Vaccination & Thrombosis – NI Update 22/4/21 – Dr Claire Corrigan & Dr Gary Benson
DoH & JCVI statement on use of the AstraZeneca COVID-19 vaccine: 7 April 2021
Patient Info – PHE – COVID-19 vaccination and blood clotting Information about your vaccination
—————————————
HSCB COVID-19 INTRANET PAGE
**Please see the HSCB Intranet for the latest Resources**
Please note some links will only work within the HSC network
HSCB Update 20/4/21 on AZ Supply
DoH & JCVI statement on use of the AstraZeneca COVID-19 vaccine: 7 April 2021
Covid-19 vaccination LES 2021 specification UPDATE 26 MAR 2021
HSS(MD) 26/2021 VACCINATION PROTOCOL FOR COVID-19 VACCINE ASTRAZENECA
Covid-19 Vaccine Update letter 19 March
26/2/21 -Commencement of 2nd Doses of Covid AZ Vaccine
23/2/21 – Priority Group 6 Clarification
22/1/21 Letter to all GPs – Covid 19 Vaccination – Next Priority Groups
Covid 19 Vaccination Programme 2021-22 – 5/1/21
HSCB PHA COVID-19 AstraZeneca vaccine PGD v1.07
Letter to all GPs : Timing of 2nd dose of Covid-19 Vaccination 13/01/21
—————————————
HSCB FAQS
Link to HSCB Hosted AstraZeneca Vaccine FAQs
Password is in the email ‘ COVID-19 & Flu Update 17 February’ from [email protected]
FAQs are correct on that date, subject to change as information develops
IF you are having difficulty you can access the GPNI PDF version below – this will be the latest version on the date specified by the file name.
COVID-19 Vaccination FAQs updated 26th May
—————————————
COVID-19 Vaccination Pathways for Care Homes
To support access to the COVID-19 vaccine for those residents who may have missed the opportunity to be vaccinated within the initial roll out by HSC Trusts to Care Homes.
COVID-19 Vaccination Pathways 08 Feb 2021
—————————————
COVID-19 vaccination for people aged 16 & 17 in at risk group (priority group 6)
As the AstraZeneca vaccine used by GPs is only licenced for people aged 18 or over, 16 & 17 year olds identified as being Clinically Extremely Vulnerable or at risk will need to have Pfizer vaccine which is used in the vaccination centres.
When practices run their “Clinically Extremely Vulnerable” and “at risk” searches, they should identify patients aged 16 & 17 but not call them for vaccination in the practice.
Patients aged 16 & 17 should be actively encouraged to book for vaccination at the centres which are using Pfizer which is approved for people aged 16 or over. The portal now has an option for clinically extremely vulnerable and for clinically vulnerable aged 16 & 17.
HSC / Other NI Updates
——————————————–
Department of Health Updates
DOH COVID-19 Vaccination programme Phased Plan
Priority groups for coronavirus (COVID-19) vaccination: advice from the JCVI
PHA – Professional guidance and information on the COVID-19 Vaccination Programme
——————————————–
HSS MD 4 2021 Interval between COVID-19 Vaccine Doses 8/1/21
- JCVI has now recommended that as many people on the JCVI priority list as possible should be offered a first vaccine dose as the initial priority. The second dose of the AstraZeneca (Oxford) vaccine may be given between 4 to 12 weeks following the first dose.Printed patient leaflets are being distributed. Unfortunately these reference the original 3-4 week interval for the second dose. New versions will be printed and issued as soon as possible. Joint CMO Letter – Public Health rationale for close one priority strategy for COVID
- Updated advice for pregnant women and women who are breast feeding.
——————————————–
RCOG – COVID-19 vaccines and pregnancy
——————————————–
Public Health Agency Updates
PHA – Professional guidance and information on the COVID-19 Vaccination Programme
Infection control guidance for adult COVID-19 vaccination clinics
——————————————–
Other NI Organisations
Communication / Public FAQs
The COVID-19 Vaccine Communication Handbook : This project tracks behavioural science evidence and advice about COVID-19 vaccine uptake.
BSI – A guide to vaccinations for COVID19
HSCB is maintaining a FAQ for the public regarding the GP COVID-19 vaccine rollout and you may find this helpful where patients have questions. The link is http://www.hscboard.hscni.net/coronavirus/covid-19-vaccination-programme/.
The PHA also have some helpful FAQs for the public at https://www.publichealth.hscni.net/covid-19-coronavirus/northern-ireland-covid-19-vaccination-programme/covid-19-vaccination-programme
Yellow Card
Report suspected side effects to medicines, vaccines or medical device and diagnostic adverse incidents used in coronavirus treatment to the Medicines and Healthcare products Regulatory Agency to ensure safe and effective use
MHRA weekly summary / analysis of yellow card reporting data (09/12/2020 to 24/01/2021).
Pharmacy Information
Community Pharmacy Vaccination
GP Update Community Pharmacy Vaccination – 31/03/21
—————————–
HSS(MD) 2 2021 – DEPLOYMENT OF COVID-19 VACCINE OXFORD – ASTRAZENECA
Governance, Handling & Preparation in GP
—————————–
Specialist Pharmacy Service – COVID Vaccine Hub
—————————————-
Suitability for COVID-19 vaccination based on prior allergy or current dietary practices
Using COVID-19 vaccines in patient taking immunosuppressive medicines
MHRA response to Irish authorities’ action to temporarily suspend the AstraZeneca COVID-19 Vaccine
Additional UK Resources
PHE: COVID-19 Vaccination : Information for Healthcare Practitioners
intended for healthcare staff involved in delivering the programme. It includes detailed information on:
- the background of the programme
- the vaccines (as they become available)
- vaccine recommendations and eligibility
- contraindications and precautions
- vaccine administration issues
GOV.UK Resource Page : https://www.gov.uk/government/collections/covid-19-vaccination-programme
Training Resources
COVID-19 Vaccination Training
All vaccinators must be registered health care professionals. Health care assistants may support vaccinators including post vaccination observation but may not administer the vaccine as part of this service.
All vaccinators should complete the COVID-19 vaccinator competency assessment tool Any training needs identified by the COVID-19 vaccinator competency assessment tool should be addressed. Copies of the assessments should be held in the practice. Additional training and information is available on the PHA website.
All vaccinators should complete the e-learning for health module on COVID-19.
Basic Life Support
Anaphylaxis
HSS-MD-85-2020-ADRENALINE-FOR-ANAPHYLAXIS-KITS-A-REMINDER-TO-HEALTH-CARE-PROFESSIONALS
RCUK’s expert anaphylaxis group is currently updating the anaphylaxis guidelines for 2021. In light of the current mass vaccination programme they have provided updated information for use in any vaccination setting to give clear guidance to healthcare professionals involved. We have also produced a poster of the algorithm for the management of anaphylaxis in the vaccination setting.
Running a vaccination clinic
Resources for Running a Clinic
PHA Guidance
Infection control guidance for adult COVID-19 vaccination clinics
———————————-
RCGP Guidance
Larger or offsite clinics
Our colleagues in regional emergency planning want to ensure that the emergency services, DfI Roads and councils are aware of the locations of larger or off-site COVID-19 vaccination clinics in case there are steps that can be taken to aid the clinics or if you need emergency assistance, for example:
o If you need to seek help from NIAS e.g. anaphylaxis
o If you need to seek help from PSNI re traffic issues or other problems
o So DfI Roads can consider their winter gritting programme in these areas
HSCB would be grateful if you would let your PSM know as soon as possible please about any large or off-site clinics being planned
Leaflets & Posters
COVID-19 Vaccination Programme information materials | HSC Public Health Agency (hscni.net)
COVID-19 vaccination – protection for health and social care workers
A guide to COVID-19 vaccination – all women of childbearing age
What to expect after your COVID-19 vaccination
COVID-19 vaccination – a guide for adults
JCVI UPDATE ON ADVICE FOR COVID-19 VACCINATION OF CHILDREN AND YOUNG PEOPLE (Primary vaccination of 5-11 year olds & Booster Vaccination in persons aged 12 to 17 years)
JCVI has now issued updated advice in relation to COVID-19 vaccination of children and young people. The full JCVI statement can be found here at https://www.gov.uk/government/publications/jcvi-update-on-advice-for-covid-19-vaccination-of-children-and-young-people/jcvi-statement-on-covid-19- vaccination-of-children-and-young-people-22-december-2021 Primary vaccination in children aged 5 to 11 years JCVI have now recommended that children aged five to 11 years in a clinical risk group (as...
COVID-19 Vaccination Medical Exemption – Clinician Guidance
COVID-19 certificates can be used to demonstrate an individual’s vaccine status and may be required as a condition of entry to specified venues. While the majority of individuals are able to safely receive COVID-19 vaccination, there are a very small number of individualswho have conditions which mean that vaccination may not be possible or in their best interests. These individuals, who are medically exempt from vaccination, need an alternative method of gaining COVID-19 certification so...
SUSPENSION OF THE 15 MINUTE WITH MRNA VACCINE FOR COVID 19
The four Chief Medical Officers of the UK and lead DCMOs for vaccines have considered whether, in the light of the very considerable need to speed up vaccination and boosting in the light of the omicron variant the 15 minute wait for some mRNA Covid-19 vaccines should be temporally suspended. [divi_wpfd_single_file file_params="{%22selected_file_id%22:34088,%22selected_category_id%22:113,%22selected_file_name%22:%22HSS MD 82 2021 Suspension of the 15 minute with MRNA Vaccine for COVID...
Suspension of the 15-minute wait for vaccination with mRNA vaccine for COVID-19: UK CMOs’ opinion
The Chief Medical Officers (CMOs) of the UK and lead Deputy Chief Medical Officers (DCMOs) for vaccines have considered whether, in the light of the very considerable need to speed up vaccination and boosting in response to Omicron variant, the 15-minute wait for some mRNA COVID-19 vaccines should be suspended. Their view, having considered the views of the COVID-19 Vaccine Benefit-Risk Expert Working Group (EWG), NHS planners and others is that with the low rates of anaphylaxis, in the...
UK vaccine response to the Omicron variant: JCVI advice
Booster vaccination eligibility should be expanded to include all adults aged 18 years to 39 years. Booster vaccination should now be offered in order of descending age groups, with priority given to the vaccination of older adults and those in a COVID-19 at-risk group. Booster vaccination should not be given within 3 months of completion of the primary course. Severely immunosuppressed individuals who have completed their primary course (3 doses) should be offered a booster dose with a...
